Alcon bought Aerie Pharmaceuticals Aerie Pharmaceuticals from 11/22/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Alcon completed its acquisition of Aerie Pharmaceuticals for $770 million, or 15.25 per share.

Aerie Pharmaceuticals

Review

Source:

{source} pictogram

investor.alcon.com

Vladimir Petenev

News editor

Write your comment first

News feed

DEC reported for 2023 by IFRS

4/5/24 DVEC

YTEK reported for 2023 by RAS

4/5/24 YAKG

ITC reported for 2023 by IFRS

4/5/24 WTCM

VK has increased its stake in Tetrick to 86%

4/5/24 VKCO

Samolet enters the market of Rostov-on-Don

4/5/24 SMLT

SFI shareholders approved the redemption of 55% of the company's shares

4/5/24 SFIN

Delimobil expects to increase its fleet to 30,000 cars

4/5/24 DELI

Segezha will create a repair base for forestry equipment in Karelia

4/5/24 SGZH

Whoosh is expanding geographic footprint

4/5/24 WUSH

Zaimer started collecting applications for participation in the IPO

4/5/24 ZAYM